Safety - OPEN Foundation

Key interindividual determinants in MDMA pharmacodynamics

Papaseit, E., Torrens, M., Pérez-Mañá, C., Muga, R., & Farré, M. | Expert opinion on drug metabolism & toxicology | 14 February 2018

Evaluating the abuse potential of psychedelic drugs for medical use in humans

Heal, D. J., Gosden, J., & Smith, S. L. | Neuropharmacology | 7 February 2018

Is LSD toxic?

Nichols, D. E., & Grob, C. S. | Forensic science international | 2 February 2018

Psychedelics and the essential importance of context

Carhart-Harris, R. L., Roseman, L., Haijen, E., Erritzoe, D., Branchi, I., & Kaelen, M. | Journal of Psychopharmacology | 1 February 2018

Key interindividual determinants in MDMA pharmacodynamics.

Papaseit, E., Torrens, M., Pérez-Mañá, C., Muga, R., & Farré, M. | Expert opinion on drug metabolism & toxicology | 16 January 2017

A regulatory perspective on the evaluation of hallucinogen drugs for human use

Calderon, S. N., Hunt, J., & Klein, M. | Neuropharmacology | 24 November 2017

Regulation of human research with LSD in the United States (1949-1987)

Bonson, K. R. | Psychopharmacology | 17 November 2017

Psychedelic Drugs in Biomedicine

Kyzar, E. J., Nichols, C. D., Gainetdinov, R. R., Nichols, D. E., & Kalueff, A. V. | Trends in Pharmacological Sciences | 22 September 2017

MDMA and brain activity during neurocognitive performance: An overview of neuroimaging studies with abstinent ‘Ecstasy’ users

Roberts, C. A., Quednow, B. B., Montgomery, C., & Parrott, A. C. | Neuroscience & Biobehavioral Reviews | 8 August 2017

Side-effects associated with ketamine use in depression: a systematic review

Short, B., Fong, J., Galvez, V., Shelker, W., & Loo, C. K. | The Lancet Psychiatry | 27 July 2017

Psychedelic drug use in healthy individuals: A review of benefits, costs, and implications for drug policy

Elsey, J. W. | Drug Science, Policy and Law | 26 July 2017

First time view on human metabolome changes after a single intake of 3,4 methylenedioxymethamphetamine (MDMA) in healthy placebo-controlled subjects

Boxler, M. I., Liechti, M. E., Schmid, Y., Kraemer, T., & Steuer, A. E. | Journal of Proteome Research | 19 July 2017

LSD treatment in Scandinavia: emphasizing indications and short-term treatment outcomes of 151 patients in Denmark

Larsen, J. K. | Nordic Journal of Psychiatry | 5 July 2017

Ayahuasca: what mental health professionals need to know

Santos, R. G. D., Bouso, J. C., & Hallak, J. E. C. | Archives of Clinical Psychiatry (São Paulo) | 1 July 2017

Isolated non-cardiogenic pulmonary edema – A rare complication of MDMA toxicity

Haaland, A., Warman, E., Pushkar, I., Likourezos, A., & Friedman, M. S. | The American journal of emergency medicine | 27 June 2017

Low-dose ketamine for treatment resistant depression in an academic clinical practice setting

Feifel, D., Malcolm, B., Boggie, D., & Lee, K. | Journal of affective disorders | 20 June 2017

A review on traditional uses, phytochemistry, pharmacology, pharmacokinetics and toxicology of the genus Peganum

Li, S., Cheng, X., & Wang, C. | Journal of Ethnopharmacology | 5 May 2017

Modern Clinical Research on LSD

Liechti, M. E. | Neuropsychopharmacology | 27 April 2017

Ketamine for Depression, 1: Clinical Summary of Issues Related to Efficacy, Adverse Effects, and Mechanism of Action

Andrade, C. | The Journal of clinical psychiatry | 1 April 2017

A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders

Sanacora, G., Frye, M. A., McDonald, W., Mathew, S. J., Turner, M. S., Schatzberg, A. F., ... & Nemeroff, C. B. | Jama psychiatry | 1 April 2017

Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults

Brown, R. T., Nicholas, C. R., Cozzi, N. V., Gassman, M. C., Cooper, K. M., Muller, D., ... & Hutson, P. R. | Clinical Pharmacokinetics | 28 March 2017

Altered peripheral immune profiles in treatment-resistant depression: response to ketamine and prediction of treatment outcome

Kiraly, D. D., Horn, S. R., Van Dam, N. T., Costi, S., Schwartz, J., Kim-Schulze, S., ... & Iosifescu, D. V. | Translational psychiatry | 21 March 2017